Search research articles
Contact Us
Filters
Showing results (131-140 of 143) with videos related to
Page
of 15
Sort By:
Circulation
|
October 12, 2020
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF
Pardeep S Jhund, Scott D Solomon, Kieran F Docherty, et al.
Nature Medicine
|
August 27, 2022
Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER
Pardeep S Jhund, Toru Kondo, Jawad H Butt, et al.
Circulation
|
September 5, 2020
Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF
Kieran F Docherty, Pardeep S Jhund, Inder Anand, et al.
European Journal of Heart Failure
|
March 2, 2026
SUBCUT HF II: rationale and design of a multicentre randomized controlled trial of SUBCUTaneous furosemide to support early discharge in patients admitted to hospital due to Heart Failure
Ross T Campbell, Joanna Osmanska, Kieran F Docherty, et al.
JACC. Heart Failure
|
March 7, 2023
Dapagliflozin in Black and White Patients With Heart Failure Across the Ejection Fraction Spectrum
Jawad H Butt, Kieran F Docherty, Brian L Claggett, et al.
JAMA
|
November 7, 2025
Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria: A Meta-Analysis
Natalie Staplin, Alistair J Roddick, Brendon L Neuen, et al.
Circulation
|
November 13, 2020
Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)
Matthew M Y Lee, Katriona J M Brooksbank, Kirsty Wetherall, et al.
European Heart Journal
|
August 22, 2020
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)
Matteo Serenelli, Michael Böhm, Silvio E Inzucchi, et al.
JAMA
|
November 7, 2025
SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-Analysis
Brendon L Neuen, Robert A Fletcher, Stefan D Anker, et al.
Circulation
|
July 17, 2020
Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF
Alice M Jackson, Pooja Dewan, Inder S Anand, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 143) with videos related to
Sort By:
Page
of 15
Circulation
|
October 12, 2020
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF
Pardeep S Jhund, Scott D Solomon, Kieran F Docherty, et al.
Nature Medicine
|
August 27, 2022
Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER
Pardeep S Jhund, Toru Kondo, Jawad H Butt, et al.
Circulation
|
September 5, 2020
Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF
Kieran F Docherty, Pardeep S Jhund, Inder Anand, et al.
European Journal of Heart Failure
|
March 2, 2026
SUBCUT HF II: rationale and design of a multicentre randomized controlled trial of SUBCUTaneous furosemide to support early discharge in patients admitted to hospital due to Heart Failure
Ross T Campbell, Joanna Osmanska, Kieran F Docherty, et al.
JACC. Heart Failure
|
March 7, 2023
Dapagliflozin in Black and White Patients With Heart Failure Across the Ejection Fraction Spectrum
Jawad H Butt, Kieran F Docherty, Brian L Claggett, et al.
JAMA
|
November 7, 2025
Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria: A Meta-Analysis
Natalie Staplin, Alistair J Roddick, Brendon L Neuen, et al.
Circulation
|
November 13, 2020
Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)
Matthew M Y Lee, Katriona J M Brooksbank, Kirsty Wetherall, et al.
European Heart Journal
|
August 22, 2020
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)
Matteo Serenelli, Michael Böhm, Silvio E Inzucchi, et al.
JAMA
|
November 7, 2025
SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-Analysis
Brendon L Neuen, Robert A Fletcher, Stefan D Anker, et al.
Circulation
|
July 17, 2020
Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF
Alice M Jackson, Pooja Dewan, Inder S Anand, et al.
Page
of 15